VeriMom4-butylresorcinol é seguro durante a gravidez?
No harmonised CLP reproductive classification or SCCS/CIR reproductive advisory was found for 4‑butylresorcinol (ECHA substance page and registration dossiers). Peer‑reviewed literature on this substance deals with topical depigmentation/tyrosinase inhibition and formulation/irritation, not developmental/reproductive toxicity, so there is no evidence to justify a reproductive hazard score. Topical use can result in low but measurable exposure in adults (see formulation/penetration studies). ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.126.948?utm_source=openai))
Pregnancy-safe products containing 4-butylresorcinol
Related ingredients
Frequently asked questions
- 4-butylresorcinol é seguro durante a gravidez?
- No harmonised CLP reproductive classification or SCCS/CIR reproductive advisory was found for 4‑butylresorcinol (ECHA substance page and registration dossiers). Peer‑reviewed literature on this substance deals with topical depigmentation/tyrosinase inhibition and formulation/irritation, not developmental/reproductive toxicity, so there is no evidence to justify a reproductive hazard score. Topical use can result in low but measurable exposure in adults (see formulation/penetration studies). ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.126.948?utm_source=openai))
- 4-butylresorcinol é seguro durante a amamentação?
- As for pregnancy: no evidence or regulatory classification indicating reproductive or lactation-specific hazard was found. Topical use implies low but measurable systemic exposure in adults; therefore breastfeeding exposure is considered low/measurable but no data show transfer in milk or nursing‑infant effects. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.126.948?utm_source=openai))
- 4-butylresorcinol é seguro para a pele do bebê?
- No infant‑specific hazard or mechanistic data were identified. Per the scoring rules, because 4‑butylresorcinol has measurable dermal availability in topical formulations for adults, baby exposure is increased by +1 (immature barrier, higher surface‑area:weight), so exposure is rated moderate. No studies demonstrating infant-specific toxicity were found. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39326268/?utm_source=openai))
- Como o VeriMom pontua 4-butylresorcinol?
- O VeriMom pontua 4-butylresorcinol em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a 4-butylresorcinol na gravidez?
- Veja nossa lista curada de alternativas seguras a 4-butylresorcinol com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.